Resch, B. Nirsevimab for Respiratory Syncytial Virus Prophylaxis in Newborns and Infants. NEJM Evid. 2025; 4(3): EVIDe2400440 Doi: 10.1056/EVIDe2400440 PubMed FullText FullText_MUG